Atai Beckley, Inc. (ATAI)
3.75
+0.08
(+2.18%)
USD |
NASDAQ |
Jan 14, 10:09
Atai Beckley EPS Diluted (Quarterly): -0.2807 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Mind Medicine (MindMed), Inc. | -0.7832 |
| GeneDx Holdings Corp. | -0.2651 |
| CorMedix, Inc. | 1.259 |
| Enveric Biosciences, Inc. | -10.81 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.10M |
| Revenue (Quarterly) | 0.749M |
| Total Expenses (Quarterly) | 61.82M |
| Enterprise Value | 1.221B |
| Gross Profit Margin (Quarterly) | 68.89% |
| Profit Margin (Quarterly) | -8.16K% |
| Earnings Yield | -19.61% |
| Normalized Earnings Yield | -15.22 |